Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.20.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 16,399 $ 1,537
Prepaids and other assets 1,269 149
Deferred costs 0 76
Total current assets 17,668 1,762
Property and equipment, net 14 22
Total assets 17,682 1,784
Current liabilities:    
Accounts payable 1,214 342
Accrued expenses 1,971 621
Convertible notes 0 4,977
Convertible notes from related parties 0 690
Premium conversion derivatives 0 2,714
Total current liabilities 3,185 9,344
Warrant liabilities 27,964 0
Total liabilities 31,149 9,344
Commitments and contingencies (Note 3 and Note 9)
Stockholders' deficit    
Preferred stock, par value $0.0001; 10,000,000 and 625,000 shares authorized as of December 31, 2020 and 2019, respectively; no shares issued and outstanding at December 31, 2020 and 2019. 0 0
Common stock, par value $0.0001; 75,000,000 and 5,000,000 shares authorized as of December 31, 2020 and 2019, respectively; 10,882,495 and 2,852,485 shares issued and outstanding at December 31, 2020 and 2019, respectively. 1 0
Additional paid-in-capital 19,207 495
Accumulated deficit (32,675) (8,055)
Total stockholders' deficit (13,467) (7,560)
Total liabilities and stockholders' deficit $ 17,682 $ 1,784